Experts have warned that few patient groups have formal policies governing corporate funding and financial transparency, despite widespread backing from the pharma industry.
Mergers and acquisitions in digital health bounced back strongly in Q2 after almost grinding to a halt at the start of the year, according to figures released this week.
UK biotech investor Arix Bioscience is looking for a new CEO after Joe Anderson decided to focus on running the investment side of the business and a reshuffle of its board.
Digital health entrepreneurs will get the chance to test and expand their businesses as part of an initiative run by San Francisco-based seed investor and mentor, Launchpad Digital Health.<